Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 11,961 - 11,980 results of 37,267 for search '(( 5 ((mean decrease) OR (nn decrease)) ) OR ( 100 ((we decrease) OR (a decrease)) ))', query time: 1.16s Refine Results
  1. 11961
    EGCG and luteolin do not synergistically reduce WPMY-1 cell proliferation and viability.

    EGCG and luteolin do not synergistically reduce WPMY-1 cell proliferation and viability. by Alana L. Gray (637670)

    Published 2014
    Save to List
    Saved in:
  2. 11962
    <i>In vitro</i> and <i>in vivo</i> properties of aminotriazines used in this study.

    <i>In vitro</i> and <i>in vivo</i> properties of aminotriazines used in this study. by David J. Matson (625974)

    Published 2015
    Save to List
    Saved in:
  3. 11963
    Varying dose.

    Varying dose. by Brenda Lyn A. Gavina (15285185)

    Published 2023
    Save to List
    Saved in:
  4. 11964
    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF

    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  5. 11965
    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF

    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  6. 11966
    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF

    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  7. 11967
    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF

    Image_3_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  8. 11968
    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF

    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  9. 11969
    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF

    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  10. 11970
    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx

    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  11. 11971
    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx

    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  12. 11972
    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF

    Image_2_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  13. 11973
    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx

    Data_Sheet_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.docx by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  14. 11974
    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF

    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  15. 11975
    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF

    Image_1_Phenotypic Effects of Wild-Type and Mutant SOD1 Expression in N9 Murine Microglia at Steady State, Inflammatory and Immunomodulatory Conditions.TIF by Ana Rita Vaz (6566963)

    Published 2019
    “…Treatment with GUDCA or VS led to a decrease of TNF-α, IL-1β, HMGB1, S100B and miR-155 in hSOD1<sup>G93A</sup> microglia. …”
    Save to List
    Saved in:
  16. 11976
    Hypomethylation of the Intron 1 CpG island results in WT1 expression.

    Hypomethylation of the Intron 1 CpG island results in WT1 expression. by Gregory McCarty (708081)

    Published 2015
    Save to List
    Saved in:
  17. 11977
    Importance of HIF-1α and TET2/3 in CoCl<sub>2</sub>-mediated induction of WT1 and WT1 lncRNA.

    Importance of HIF-1α and TET2/3 in CoCl<sub>2</sub>-mediated induction of WT1 and WT1 lncRNA. by Gregory McCarty (708081)

    Published 2015
    Save to List
    Saved in:
  18. 11978
    The influence of fluoxetine treatment on <i>P</i>. <i>berghei</i> pathogenesis.

    The influence of fluoxetine treatment on <i>P</i>. <i>berghei</i> pathogenesis. by Li Gao (131516)

    Published 2024
    Save to List
    Saved in:
  19. 11979
    Expression of Ki67 antigen and induction of apoptosis in response to resveratrol treatment.

    Expression of Ki67 antigen and induction of apoptosis in response to resveratrol treatment. by Mehtap Kilic Eren (591048)

    Published 2015
    Save to List
    Saved in:
  20. 11980
    Establishment of our drug screening model.

    Establishment of our drug screening model. by Jian-Ping Dai (142741)

    Published 2013
    “…<p>(A) Schematic representation of the drug screening model. …”
    Save to List
    Saved in:

Search Tools: